Press/Media
- 125 - 150 out of 789 results
Search results
-
Mount Sinai Study Uncovers Inflammatory Markers that May Predict a Response in Certain Patients to COVID-19 Immunotherapies
5/12/22 → 7/12/22
2 items of Media coverage
Press/Media
-
Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022
6/12/22 → 7/12/22
73 items of Media coverage
Press/Media
-
The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
6/12/22
2 items of Media coverage
Press/Media
-
Study uncovers inflammatory markers that may predict a response in certain patients to COVID-19 immunotherapies
5/12/22 → 6/12/22
3 items of Media coverage
Press/Media
-
CDK4: A master regulator of the cell cycle and its role in cancer
E. Premkumar Reddy, Poulikos Poulikakos & Samir Parekh
5/12/22
3 items of Media coverage
Press/Media
-
Mount Sinai study uncovers inflammatory markers that may predict a response in certain patients to COVID-19 immunotherapies
5/12/22
2 items of Media coverage
Press/Media
-
Master regulator of cell cycle and its role in cancer
E. Premkumar Reddy, Poulikos Poulikakos & Samir Parekh
3/12/22
1 item of Media coverage
Press/Media
-
-
Genes & Cancer | CDK4: a master regulator of the cell cycle and its role in cancer
E. Premkumar Reddy, Poulikos Poulikakos & Samir Parekh
2/12/22
2 items of Media coverage
Press/Media
-
Reports Outline Acute Leukemia Study Findings from Department of Medicine (An Mdm2 Degrader for Treatment of Acute Leukemias)
Lauren Herschbein, Bridget Marcellino & Alan Shih
1/12/22
1 item of Media coverage
Press/Media
-
Compositions and Methods for Treating EZH2-mediated Cancer
30/11/22
1 item of Media coverage
Press/Media
-
US Patent Issued to Icahn School of Medicine at Mount Sinai on Nov. 29 for "Compositions and methods for treating EZH2-mediated cancer" (New York Inventors)
30/11/22
1 item of Media coverage
Press/Media
-
Genes for Potential Long-Term Lyme Disease Diagnosis Identified
29/11/22
1 item of Media coverage
Press/Media
-
New funding of $2 million for research bringing us one step closer to a cure for Follicular Lymphoma
28/11/22 → 29/11/22
14 items of Media coverage
Press/Media
-
Dr. Mascarenhas on Advancements in the Treatment Landscape of Myelofibrosis
28/11/22
1 item of Media coverage
Press/Media
-
Genes could be key to diagnosing Lyme disease, scientists say
28/11/22
1 item of Media coverage
Press/Media
-
Expanding Treatment Options Elevate Outcomes for Patients With Myelofibrosis
28/11/22
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai Details Findings in Myeloma (Bridging Advanced Myeloma Patients To Subsequent Treatments and Clinical Trials With Classical Chemotherapy and Stem Cell Support)
Joshua Richter, Amir Steinberg, Samir Parekh & Ajai Chari
22/11/22
1 item of Media coverage
Press/Media
-
New Vaccine Approach Halts Disease After 23 Yrs of Breast Cancer
17/11/22 → 18/11/22
3 items of Media coverage
Press/Media
-
Top in hem/onc: Multiple myeloma salvage therapy; revaccination guidance after cell therapy
17/11/22
1 item of Media coverage
Press/Media
-
Genetic profiling of Lyme disease could bring new therapeutic targets
17/11/22
1 item of Media coverage
Press/Media
-
Gene Set Could Identify Patients With Post-Treatment Lyme Disease
16/11/22
1 item of Media coverage
Press/Media
-
Salvage treatments prolong survival for myeloma patients who relapse after CAR T therapy
16/11/22
1 item of Media coverage
Press/Media
-
Genes to Potentially Diagnose Long-Term Lyme Disease Identified
14/11/22 → 16/11/22
69 items of Media coverage
Press/Media
-
VIDEO: Reviewing uses of JAK2 inhibitors in myelofibrosis
16/11/22
1 item of Media coverage
Press/Media